Alzheimer's Vaccine

Featured Article

An Alzheimer's vaccine called AD02 has proceeded to Phase II clinical trials, experts say. A total of 420 patients in five European countries will be involved in the study. Currently, the results of the Phase I results of the study is confidential, but the safety of the drug has already been established, so experts say this second phase will help determine its effectiveness.


Read more

More information on "Alzheimer's Vaccine"

From Our Experts

See more SharePosts »

From Our Sources

More on Alzheimer's »